SMMT Company Profile and Key Details

Q: Who are the executives of SMMT?

Dr. Anne HeatheringtonHead of Clinical Devel. and Quantitative SciencesMr. Campbell HairHead of HR?Ms. Michelle AveryDirector of Investor RelationsMr. Will BlackHead of Information Technology?Mr. Robert W. DugganExecutive ChairmanDr. Mahkam Zanganeh D.D.S., M.B.A., MBAChief Executive Officer, Pres & DirectorMr. Ankur DhingraChief Financial OfficerDr. Urte Gayko Ph.D.Head of Regulatory Affairs, Quality Assurance & SafetyProf. Dame Kay Davies DBE, FRS CBECo-Founder, Chairman of Scientific Advisory Board and Scientific AdvisorDr. Elaine Carla Stracker J.D., Ph.D.Head of Compliance? & Gen. CounselMs. Shelley D. SprayHead of Corporation Education, Communications & Creative?Ms. Abby Guzman MurphyHead of HRMs. Divya ChariHead of Global Clinical OperationsMr. Dave GancarzSenior Vice President of Stakeholder Relations, Bus. Devel. & Corporation Strategy?

NASDAQ : SMMT

Summit Therapeutics

$14.74

0.11+0.75%

At Close 4:00 PM

69.53

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Summit Therapeutics Inc. (SMMT) stock surged +0.75%, trading at $14.74 on NASDAQ, up from the previous close of $14.63. The stock opened at $15.18, fluctuating between $14.65 and $15.71 in the recent session.

Stock Snapshot

14.63

Prev. Close

11.44B

Market Cap

14.65

Day Low

-9.21

P/E Ratio

-1.6

EPS (TTM)

-0.11

Cash Flow per Share

15.18

Open

776.16M

Number of Shares

15.705

Day High

15.59%

Free Float in %

0.11

Book Value

4.25M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 22, 2026	15.18	15.71	14.65	14.74	4.25M
Jul 21, 2026	13.67	14.72	13.63	14.63	3.92M
Jul 20, 2026	13.74	14.35	13.49	13.50	2.7M
Jul 17, 2026	13.46	14.08	13.36	13.81	2.84M
Jul 16, 2026	14.90	15.02	13.54	13.76	3.74M
Jul 15, 2026	15.62	15.62	14.94	15.07	2.3M
Jul 14, 2026	15.35	15.63	15.21	15.47	3.03M
Jul 13, 2026	15.11	15.48	14.79	15.30	3.39M
Jul 10, 2026	15.50	15.53	14.86	15.25	2.64M
Jul 09, 2026	15.60	15.88	15.45	15.48	2.36M
Jul 08, 2026	15.75	15.88	15.39	15.69	2.77M
Jul 07, 2026	15.97	16.05	15.46	15.88	2.71M
Jul 06, 2026	15.50	15.94	15.30	15.93	3.92M
Jul 02, 2026	14.55	15.70	14.55	15.42	7.09M
Jul 01, 2026	14.59	14.80	14.31	14.38	3.91M
Jun 30, 2026	14.32	14.89	14.31	14.57	5.31M
Jun 29, 2026	14.21	14.58	14.12	14.32	5.97M
Jun 26, 2026	14.00	14.25	13.88	14.01	4.17M
Jun 25, 2026	14.25	14.53	14.05	14.18	4.79M
Jun 24, 2026	14.25	14.76	14.17	14.25	6.77M

Contact Details

Miami, FL 02142

United States

https://www.smmttx.com 617 514 7149

About Company

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.

Stock Peers

ARGX

-23.02-2.63%

argenx SE$851.72 REGN

-24.01-3.56%

Regeneron Pharmaceuticals, Inc.$651.18 MDGL

-9.14-1.67%

Madrigal Pharmaceuticals, Inc.$537.65 UTHR

-8.76-1.63%

United Therapeutics Corporation$527.07 VRTX

-9.43-1.96%

Vertex Pharmaceuticals Incorporated$472.57 KRYS

-2.26-0.67%

Krystal Biotech, Inc.$336.80 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ONC

1.245+0.39%

BeOne Medicines AG$319.93 PRAX

-5.77-1.82%

Praxis Precision Medicines, Inc.$312.10 LGND

-1.21-0.40%

Ligand Pharmaceuticals Incorporated$304.26

Frequently Asked Questions

What is the current Summit Therapeutics Inc. (SMMT) stock price?

Summit Therapeutics Inc. (NASDAQ: SMMT) stock price is $14.74 in the last trading session. During the trading session, SMMT stock reached the peak price of $15.71 while $14.65 was the lowest point it dropped to. The percentage change in SMMT stock occurred in the recent session was 0.75% while the dollar amount for the price change in SMMT stock was $0.11.

SMMT's industry and sector of operation?

The NASDAQ listed SMMT is part of Biotechnology industry that operates in the broader Healthcare sector. Summit Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SMMT?

Dr. Anne Heatherington
Head of Clinical Devel. and Quantitative Sciences
Mr. Campbell Hair
Head of HR?
Ms. Michelle Avery
Director of Investor Relations
Mr. Will Black
Head of Information Technology?
Mr. Robert W. Duggan
Executive Chairman
Dr. Mahkam Zanganeh D.D.S., M.B.A., MBA
Chief Executive Officer, Pres & Director
Mr. Ankur Dhingra
Chief Financial Officer
Dr. Urte Gayko Ph.D.
Head of Regulatory Affairs, Quality Assurance & Safety
Prof. Dame Kay Davies DBE, FRS CBE
Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor
Dr. Elaine Carla Stracker J.D., Ph.D.
Head of Compliance? & Gen. Counsel
Ms. Shelley D. Spray
Head of Corporation Education, Communications & Creative?
Ms. Abby Guzman Murphy
Head of HR
Ms. Divya Chari
Head of Global Clinical Operations
Mr. Dave Gancarz
Senior Vice President of Stakeholder Relations, Bus. Devel. & Corporation Strategy?

How SMMT did perform over past 52-week?

SMMT's closing price is 17.45% higher than its 52-week low of $12.55 where as its distance from 52-week high of $30.98 is -52.42%.

How many employees does SMMT have?

Number of SMMT employees currently stands at 265.

Link for SMMT official website?

Official Website of SMMT is: https://www.smmttx.com

How do I contact SMMT?

SMMT could be contacted at phone 617 514 7149 and can also be accessed through its website. SMMT operates from 601 Brickell Key Drive, Miami, FL 02142, United States.

How many shares of SMMT are traded daily?

SMMT stock volume for the day was 4.25M shares. The average number of SMMT shares traded daily for last 3 months was 5.25M.

What is the market cap of SMMT currently?

The market value of SMMT currently stands at $11.44B with its latest stock price at $14.74 and 776.16M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	265
Beta	-1.26
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	265
Beta	-1.26
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SMMT Company Profile and Key Details

Summit Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Earnings & Analyst Outlook

Valuation Metrics

Price Forecast & Outlook

Key Takeaways